Sally C. Pipes

Commentary

Harris’ and Walz’s Healthcare Vision a Socialist One

Democrat presidential nominee Kamala Harris joined President Joe Biden at the White House last Thursday for an event on healthcare policy. The two presented a unified vision for the future of America’s health sector. But the space between them on this issue, historically speaking, is difficult to ignore. As recently as ...
Commentary

This Bipartisan Bill Would Upend America’s Pharmaceutical Industry

Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
Commentary

How the GOP can get tough on health care

Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Commentary

Medicaid’s Waivers Are Out of Control – But Also Show How to Save the Program

Are rental vouchers a form of “health care?” Federal bureaucrats evidently think so. They’ve recently approved waivers for states to fund these benefits through Medicaid, the joint federal-state health insurance program that covers over 76 million Americans. These waivers constitute an enormous federal subsidy to state governments, with up to ...
Commentary

Biden’s Disdain for Democracy Revealed in Backdoor Bailout

Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
Commentary

Scope-of-practice laws put patients in the crosshairs

New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
Commentary

JD Vance’s Healthcare Record Should Give Republicans Pause

The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
Commentary

Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary

Harris is wrong about medical debt

Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary

Read the latest on pharmaceutical benefit managers

Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.

The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Commentary

Harris’ and Walz’s Healthcare Vision a Socialist One

Democrat presidential nominee Kamala Harris joined President Joe Biden at the White House last Thursday for an event on healthcare policy. The two presented a unified vision for the future of America’s health sector. But the space between them on this issue, historically speaking, is difficult to ignore. As recently as ...
Commentary

This Bipartisan Bill Would Upend America’s Pharmaceutical Industry

Vice President Kamala Harris and Minnesota Governor Tim Walz have pivoted hard to the center in recent weeks in their bid for the White House. But their records indicate that they’d launch even more government intervention in the healthcare market. Harris was the most progressive member of the Senate during ...
Commentary

How the GOP can get tough on health care

Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Commentary

Medicaid’s Waivers Are Out of Control – But Also Show How to Save the Program

Are rental vouchers a form of “health care?” Federal bureaucrats evidently think so. They’ve recently approved waivers for states to fund these benefits through Medicaid, the joint federal-state health insurance program that covers over 76 million Americans. These waivers constitute an enormous federal subsidy to state governments, with up to ...
Commentary

Biden’s Disdain for Democracy Revealed in Backdoor Bailout

Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
Commentary

Scope-of-practice laws put patients in the crosshairs

New research appears to have found the proverbial “free lunch” economists have long been searching for. States that grant nurse practitioners “full practice authority” — that authorize them to provide care independently, without the supervision of a physician or other provider — reduce total healthcare costs for people with diabetes ...
Commentary

JD Vance’s Healthcare Record Should Give Republicans Pause

The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
Commentary

Pending Government Drug Pricing Will Harm Seniors’ Care And Budgets

Any day now, the Biden administration will publish the prices it has set for ten drugs covered by Medicare’s Part D prescription drug benefit. These price controls will provide “meaningful financial relief for millions of people with Medicare,” administration officials say. Many seniors are about to see just how false that ...
Commentary

Harris is wrong about medical debt

Is Vice President Kamala Harris trying to rebrand as a centrist? She has recently disavowed her previous progressive positions on everything from border security to fracking to “Medicare for All.” But she and her running mate remain enthusiastic about socializing medical debt. In a recent statement, Harris claimed that “more than 100 million Americans struggle with medical ...
Commentary

Read the latest on pharmaceutical benefit managers

Legislation Urgently Needed to Rein In Pharmacy Benefit Mgrs.

The U.S. House Committee on Oversight and Accountability held a hearing last month with the CEOs of the nation’s three largest pharmacy benefit managers: CVS Caremark, Express Scripts, and OptumRx. The hearing coincided with a new report from the committee on the outsized role these prescription-drug middlemen play in determining what people pay for ...
Scroll to Top